University of Cambridge — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University of Cambridge appears in 125 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials125

Recruiting shown12

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Targeted Abdominal CT in Conjunction With Lung Cancer ScreeningNCT07171190 · lead sponsor · 2025-11-11

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological ConditionsNCT07786116 · lead sponsor · 2025-11-01

taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEsNCT06844539 · lead sponsor · 2025-04-24

Closed-loop in Adults With Type 2 DiabetesNCT06579404 · lead sponsor · 2024-12-06

Optical Neuroimaging and CognitionNCT05460143 · lead sponsor · 2023-05-01

Closed-loop for People Living With Cystic Fibrosis Related DiabetesNCT05562492 · lead sponsor · 2023-04-12

ACTIVE_NOT_RECRUITING

Closing the Loop in People with Type 1 DiabetesNCT05653050 · lead sponsor · 2023-02-20

KEEP Intervention for People Newly Diagnosed With Parkinson'sNCT05253040 · lead sponsor · 2022-06-18

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)NCT05257460 · lead sponsor · 2022-01-25

Closing the Loop in Adults With Type 1 Diabetes (CLEAR)NCT04977908 · lead sponsor · 2021-08-31

FASter Insulin in Closed-loop Technology in ChildrenNCT04759144 · lead sponsor · 2021-03-12

Closed-loop in Adults With T2D Not Requiring DialysisNCT04701424 · lead sponsor · 2020-12-16

Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of HallucinationsNCT04399096 · lead sponsor · 2020-12-01

CBT to Reduce Insomnia and Improve Social Recovery in Early PsychosisNCT04180709 · lead sponsor · 2020-10-30

24/7 Closed-loop in Older Subjects With Type 1 DiabetesNCT04025762 · lead sponsor · 2019-09-01

Closing the Loop in Adults With Type 1 Diabetes Under Free Living ConditionsNCT04055480 · lead sponsor · 2019-08-10

Closed-loop in Adults With T2D Requiring DialysisNCT04025775 · lead sponsor · 2019-08-01

Breast Screening - Risk Adaptive Imaging for DensityNCT04097366 · lead sponsor · 2019-05-28

The Artificial Pancreas in Very Young Children With T1DNCT03784027 · lead sponsor · 2019-05-01

IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2NCT03194815 · lead sponsor · 2017-11-01

ACTIVE_NOT_RECRUITING

The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01)NCT03101865 · lead sponsor · 2017-08-08

Closed Loop From Onset in Type 1 DiabetesNCT02871089 · lead sponsor · 2017-01-01

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)NCT03936634 · lead sponsor · 2016-11-14

Closed-loop Insulin Delivery in the General WardNCT01774565 · lead sponsor · 2016-08-01

Home Testing of Day and Night Closed Loop With Pump Suspend FeatureNCT02523131 · lead sponsor · 2016-05-01

Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living ConditionsNCT02727231 · lead sponsor · 2016-03-01

Study of Immunotherapy in Autoantibody Positive PsychosisNCT02449746 · lead sponsor · 2015-08-01

Peripheral Immunomarker Validation in Treatment-resistant DepressionNCT02752178 · lead sponsor · 2015-06-01

Closing the Loop 24/7 in Adolescents With Type 1 DiabetesNCT01873066 · lead sponsor · 2014-08-28

Automated Closed-loop in Children and Adolescents With Type 1 DiabetesNCT02129868 · lead sponsor · 2014-04-01

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living ConditionsNCT01961622 · lead sponsor · 2014-04-01

National Cohort Study of Idiopathic and Heritable Pulmonary Arterial HypertensionNCT01907295 · lead sponsor · 2014-02-01

Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home SettingNCT01778348 · lead sponsor · 2013-12-01

Closing the Loop in Adults With Type 1 Diabetes in the Home SettingNCT01440140 · lead sponsor · 2012-12-01

Short Term Closed-loop Glucose Control in Adults With Type 1 DiabetesNCT01666028 · lead sponsor · 2012-11-01

Closing the Loop in Youth With Type 1 Diabetes in the Home SettingNCT01221467 · lead sponsor · 2012-06-01

TRANSEURO Open Label Transplant Study in Parkinson's DiseaseNCT01898390 · lead sponsor · 2012-05-01

Achieving Normal Glucose In Hospital SettingsNCT01359241 · lead sponsor · 2011-11-01

Closing the Loop in Adolescents During Non-compliance BehavioursNCT01629277 · lead sponsor · 2011-07-01

Degarelix Before Radical ProstatectomyNCT01852864 · lead sponsor · 2011-07-01

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal BolusingNCT01629251 · lead sponsor · 2011-04-01

Closing the Loop for 36 Hours in Adolescents With Type 1 DiabetesNCT01074801 · lead sponsor · 2010-03-01

Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionNCT00994617 · lead sponsor · 2010-01-01

Comparison of Single and Combination Diuretics in Low-Renin HypertensionNCT02351973 · lead sponsor · 2009-11-01

Closing the Loop in Adults With Type 1 Diabetes - Alcohol ConsumptionNCT00944619 · lead sponsor · 2009-09-01

Optimum Treatment for Drug-Resistant HypertensionNCT02369081 · lead sponsor · 2009-05-01

Automated Overnight Closed-loop Glucose Control in Young People With Type 1 DiabetesNCT00989898 · lead sponsor · 2009-02-01

Closing the Loop in Adults With Type 1 DiabetesNCT00910767 · lead sponsor · 2009-02-01

Adolescent Type 1 Diabetes Cardio-Renal Intervention TrialNCT01581476 · lead sponsor · 2009-01-01

Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 DiabetesNCT02782195 · lead sponsor · 2008-11-01

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)NCT00395200 · lead sponsor · 2008-07-01

Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential HypertensionNCT00380289 · lead sponsor · 2006-09-01

Double Blind Crossover Comparison of Diuretics in the YoungNCT00429897 · lead sponsor · 2006-08-01

A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's DiseaseNCT07157735 · collaborator · 2026-02-02

Population Based Germline Testing for Early Detection and Prevention of CancerNCT07498829 · collaborator · 2025-12-18

UK Islet Autoantibody RegistryNCT07125365 · collaborator · 2025-07-11

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung CancerNCT07008742 · collaborator · 2025-06-04

Εffectiveness of a Digital Social Intervention in Primary CareNCT06849245 · collaborator · 2025-02-25

Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary DiseaseNCT06347536 · collaborator · 2025-01-30

Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensationNCT06555757 · collaborator · 2024-09-18

Drugs studied in this sponsor's trials

27 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Cambridge as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

azithromycin2

spironolactone2

afatinib1

aldesleukin1

amiloride1

apalutamide Oral Tablet [Erleada]1

bisoprolol1

chlorthalidone1

azithromycin RxCUI 18631 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials spironolactone RxCUI 9997 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials afatinib RxCUI 1430438 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial aldesleukin RxCUI 70223 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial amiloride RxCUI 644 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial apalutamide Oral Tablet [Erleada] RxCUI 1999584 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial bisoprolol RxCUI 19484 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial chlorthalidone RxCUI 2409 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial donepezil RxCUI 135447 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial doxazosin RxCUI 49276 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial doxycycline RxCUI 3640 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial imatinib mesylate RxCUI 284924 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial isoniazid RxCUI 6038 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial isosorbide dinitrate RxCUI 6058 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial minocycline RxCUI 6980 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial mirtazapine RxCUI 15996 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial moxifloxacin RxCUI 139462 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pazopanib RxCUI 714438 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pyridoxine hydrochloride RxCUI 203164 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial raltegravir RxCUI 719872 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rifampin RxCUI 9384 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial riociguat RxCUI 1439816 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rituximab RxCUI 121191 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator72

lead sponsor53

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.